UiPath (NYSE:PATH) Trading 1.2% Higher

UiPath Inc. (NYSE:PATH)’s stock price traded up 1.2% during trading on Monday . The company traded as high as $19.90 and last traded at $19.72. 1,466,209 shares were traded during mid-day trading, a decline of 83% from the average session volume of 8,384,261 shares. The stock had previously closed at $19.48.

Wall Street Analyst Weigh In

Several analysts have issued reports on PATH shares. DA Davidson increased their target price on UiPath from $20.00 to $24.00 and gave the company a “neutral” rating in a research report on Thursday, March 14th. BMO Capital Markets boosted their target price on shares of UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a report on Thursday, March 14th. Scotiabank raised their price target on shares of UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a report on Thursday, March 14th. KeyCorp began coverage on shares of UiPath in a research note on Monday, April 8th. They set an “overweight” rating and a $27.00 price objective for the company. Finally, Mizuho raised their target price on shares of UiPath from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, UiPath presently has an average rating of “Moderate Buy” and an average target price of $27.41.

UiPath Stock Performance

The business’s 50 day moving average price is $21.60 and its 200 day moving average price is $21.78. The firm has a market cap of $11.32 billion, a price-to-earnings ratio of -117.06 and a beta of 1.01.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The company had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. Sell-side analysts anticipate that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Ashim Gupta sold 16,000 shares of UiPath stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the sale, the chief financial officer now owns 87,505 shares of the company’s stock, valued at approximately $1,998,614.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders have sold 96,000 shares of company stock worth $2,023,440. 31.03% of the stock is owned by corporate insiders.

Institutional Trading of UiPath

A number of institutional investors have recently made changes to their positions in PATH. Mark Sheptoff Financial Planning LLC acquired a new stake in UiPath in the 4th quarter valued at about $25,000. HighMark Wealth Management LLC acquired a new position in UiPath during the fourth quarter worth $27,000. Cypress Capital Management LLC WY purchased a new stake in UiPath in the 4th quarter valued at $29,000. ORG Partners LLC increased its stake in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares during the last quarter. Finally, GAMMA Investing LLC purchased a new position in shares of UiPath during the 4th quarter worth $36,000. 62.50% of the stock is owned by institutional investors and hedge funds.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.